26/12/2025
International Dossier Evaluation is the systematic, evidence-based appraisal of a Common Technical Document (CTD/eCTD) by national regulatory authorities (NRAs) to confirm the safety, efficacy and quality of a health product before approval. Harmonised guidelines from the ICH, EMA, FDA, WHO and SAHPRA increasingly promote work-sharing, reliance and electronic formats, allowing well-prepared dossiers to move faster across borders.
This article explains the principles, benefits and challenges of international dossier review and shows how MC Pharma’s regulatory team helps sponsors navigate each stage from technical gap analysis to post-approval life-cycle management.
Explore SAHPRA reliance pathways, AMA harmonisation and MC Pharma’s end-to-end regulatory services.